Fundraising Fox
Faze Medicines
Cambridge, US · Founded 2018 · Delaware corporation · 3 employees on LinkedIn · 2 known investors
Find your way into Faze Medicines
Sign up to find every way you can get introduced to Faze Medicines
- Your email: who you already know at Faze Medicines, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Faze Medicines team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Founders & leadership
EF
Ed FreedmanNamed on SEC filing
Board
CP
RT
CH
Investors · 2
Novartis Venture FundreportedBasel · $5M – $25M
How we know: funding news · Not right? Tell us
Third Rock VenturesreportedBoston · $100K – $5Mvia Charles Homcy · board
How we know: a partner's Signal profile · board seat on SEC Form D · offering press articles · funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$30.4M disclosed across 1 round · 2020
▶$30.4MraisedDec 2020 · 9 investors · BiotechnologyRule 506(b)
▶$30.4MraisedDec 2020 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Cary PfefferExecutive Officer, Director
- Ed FreedmanExecutive Officer, Director
- Robert TepperDirector
- Charles HomcyDirector
- Offering amount
- $81M
- Amount sold
- $30.4M
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Faze Medicines's investors?
- Faze Medicines's investors include Novartis Venture Fund, Third Rock Ventures.
- How much funding has Faze Medicines raised?
- Faze Medicines has disclosed $30.4M raised across 1 round.
- Where is Faze Medicines headquartered?
- Faze Medicines is headquartered in Cambridge, US.